Page last updated: 2024-10-24

cefuroxime and Psoriasis

cefuroxime has been researched along with Psoriasis in 1 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Walecka, I1
Olszewska, M1
Rakowska, A1
Slowinska, M1
Sicinska, J1
Piekarczyk, E1
Kowalska-Oledzka, E1
Goralska, B1
Rudnicka, L1

Other Studies

1 other study available for cefuroxime and Psoriasis

ArticleYear
Improvement of psoriasis after antibiotic therapy with cefuroxime axetil.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2009, Volume: 23, Issue:8

    Topics: Adult; Aged; Anti-Bacterial Agents; Cefuroxime; Dose-Response Relationship, Drug; Female; Humans; Ma

2009